H-1B and green card employer
AstraZeneca Pharmaceuticals LP
Wilmington, DE NAICS 32541
AstraZeneca Pharmaceuticals's new-hire H-1B offers average 3.1 lottery entries, against 2.1 for all employers.
120certified H-1B LCAs, Jul 2025 to Jun 2026
$157,517median offer · middle half $136k to $195k
10%99 vs. 110 LCAs, Oct 2025 to Jun 2026 vs. a year earlier
6certified green card (PERM) cases, FY2026 to Jun 2026
Source U.S. Dept. of Labor, OFLC disclosure files Covers decisions Jul 2025 to Jun 2026 Release FY2026 Q3, published Aug 7, 2026 Wage levels OFLC 2026-27
Lottery entries at AstraZeneca Pharmaceuticals's offers
49 new-employment LCAs · OFLC 2026-27Of every 100 new-employment filings at AstraZeneca Pharmaceuticals:
6 get one entry, incl. 2 under Level I
22 get two entries
25 get three entries
47 get four entries
Compared with all employers
1 entry · Level I2 · Level II3 · Level III4 · Level IVunder Level I, still 1 entry
How this is calculated
New-employment H-1B LCAs only, the filings behind most cap petitions; extensions, transfers and amendments do not go through the lottery, and cap-exempt universities and nonprofit research organizations are left out. Each offered salary (low end of the range) is compared with the OFLC Level I to IV wages for its occupation and worksite area, wage year 2026-27; a filing with several worksites counts at its lowest level, as the rule requires. Numbers on the right are LCAs. Full methodology.
On the 2025-26 table, used for the March 2026 registration, the same offers average 3.2 entries (51% at Level IV).
Level stated vs level reached
all certified LCAs vs new-employment offersThe level an employer writes on the LCA is the prevailing-wage floor it chose for the job. The salary it offers can sit higher. The lottery counts the salary.
1 entry · Level I2 · Level II3 · Level III4 · Level IVunder Level I, still 1 entry
How this is calculated
New-employment H-1B LCAs only, the filings behind most cap petitions; extensions, transfers and amendments do not go through the lottery, and cap-exempt universities and nonprofit research organizations are left out. Each offered salary (low end of the range) is compared with the OFLC Level I to IV wages for its occupation and worksite area, wage year 2026-27; a filing with several worksites counts at its lowest level, as the rule requires. Numbers on the right are LCAs. Full methodology.
What AstraZeneca Pharmaceuticals offers
120 certified LCAs, Jul 2025 to Jun 2026$50k$100k$150k$200k$250k$300k
Level IIIIIIIVunder Level I = 1 LCA = 1 LCA
$10,000 bands, coloured by the level each salary reaches for its own job and area.
By fiscal year
October to September · hatched: FY2026 to Jun 2026Certified H-1B LCAs
99 FY2026 to Jun 2026
Median offer
$155,000 FY2026
Certified green card cases
6 FY2026 to Jun 2026
Jobs and worksites
Jul 2025 to Jun 2026Top jobs
| Job | Certified LCAs | Median salary |
|---|---|---|
| Medical Scientists, Except Epidemiologists | 22 | $163,444 |
| Biological Scientists, All Other | 21 | $130,701 |
| Statisticians | 19 | $161,616 |
| Biochemists and Biophysicists | 15 | $134,971 |
| Data Scientists | 11 | $194,537 |
| Managers, All Other | 8 | $212,500 |
| Industrial Engineers | 4 | $141,076 |
| Marketing Managers | 3 | $179,974 |
Top worksite cities
| City | Certified LCAs | Median salary |
|---|---|---|
| Gaithersburg, MD | 69 | $155,085 |
| Waltham, MA | 20 | $144,270 |
| Wilmington, DE | 15 | $185,329 |
| Boston, MA | 4 | $205,044 |
| Cambridge, MA | 3 | $138,511 |
Green card (PERM) labor certifications
by fiscal year of decision| Fiscal year | Certified | Denied | Median offer |
|---|---|---|---|
| FY2023 | 16 | 0 | $128,280 |
| FY2024 | 18 | 0 | $130,048 |
| FY2025 | 13 | 0 | $155,958 |
| FY2026 to Jun 2026 | 6 | 0 | $170,273 |
Review takes about a year, so a pause in filing shows up a year later. Medians only for years with 3 or more certifications.
Recent certified LCAs
latest 25 · salary is the low end of the offered range| Job title | Salary | Entries |
|---|---|---|
| Senior Medical Science Liason - Lung | $218,069 | |
| Senior Scientist, Bioscience | $145,000 | |
| Statistical Programming Director | $215,000 | |
| Study Physician Lung Cancer | $309,000 | |
| Senior Manager, ENHERTU Marketing | $179,974 | |
| Senior Manager, ENHERTU Marketing | $179,974 | |
| Senior Statistician II | $153,000 | |
| Assoc. Princ. Scientist, Vector Engineering & Cell Line Dev. | $161,000 | |
| Senior Scientist, Translational Medicine | $138,439 | |
| Product Owner | $175,835 | |
| Statistical Programming Director | $228,302 | |
| Statistical Science Associate Director | $177,229 | |
| Senior Scientist, Chromatographic Separations | $140,689 | |
| Senior Scientist | $129,168 | |
| Senior Scientist | $138,511 | |
| Quality Assurance Specialist IV | $140,189 | |
| Labeling Systems Analyst | $89,503 | |
| Scientist | $113,631 | |
| Global Forecasting Leader | $225,075 | |
| Associate Director, Statistical Programming | $155,000 | |
| Global Development Medical Dir, Late Development Oncology | $260,099 | |
| Clinical Supply Study Lead | $109,881 | |
| Senior Scientist, Protein Engineering and Novel Modalities | $134,971 | |
| Scientist, Analytical Sciences | $99,250 | |
| Global Regulatory Affairs Director | $195,000 |